shishi luo (@shishiluo) profile picture

Viral evolution, bioinformatics, stochastic processes, mathematical modeling. @my_helix

Joined February 2013
Photo by shishi luo (@shishiluo)Photo by shishi luo (@shishiluo)Photo by shishi luo (@shishiluo)Photo by shishi luo (@shishiluo)Photo by shishi luo (@shishiluo)Photo by shishi luo (@shishiluo)Photo by shishi luo (@shishiluo)Photo by shishi luo (@shishiluo)Photo by shishi luo (@shishiluo)Photo by shishi luo (@shishiluo)
Replying to @my_helix
@my_helix's latest preprint on COVID vax protection against severe illness during 2023-24 respiratory season. Highlights: - XBB.1.5-based booster provided add'l protection over the 2023 booster - Potentially lower XBB.1.5 mRNA vaccine protection against JN.1 vs XBB variants
XBB.1.5 mRNA COVID-19 Vaccination and Inpatient or Emergency Department Visits Among Adults Infected with SARS-CoV-2 JN.1 and XBB-Lineage Variants medrxiv.org/cgi/content/shor… #medRxiv
1
1
224
shishi luo retweeted
Electric service has begun on the Caltrain corridor! And yes, there will be multiple trains today that will be electric! 🤭🫶🏼⚡️
64
169
86
1,539
204,029
shishi luo retweeted
Join us in officially welcoming Hylton Kalvaria as SVP of Life Sciences. CEO James Lu said: “Strengthening our team with Hylton further positions Helix to ensure the power of genomics is used to improve healthcare outcomes on the largest possible scale.” bwnews.pr/3IxHsCM
1
2
3
398
shishi luo retweeted
#InTheNews: @USNews spoke w/head of infectious diseases, @shishiluo, about the winter COVID-19 wave, saying Helix’s data shows the benefits of COVID-19 vaccines among older populations and future vaccine campaigns might be more targeted to that age group. bit.ly/493UlA3
2
328
Great to see @my_helix 's research on infectious diseases picked up by the popular TWiV podcast (starts about the 27th minute)! COVID isn't likely to go away soon, and our work shows that more could be done to treat and prevent severe cases.
77
Congrats to @alexbolze and coauthors on research demonstrating how personalized genetics can help defer breast cancer screening for those at low risk. Read the feature on GenomeWeb: genomeweb.com/sequencing/bre…
#OnTheBlog: We summarize our newest JAMA Oncology publication that demonstrates how genetic testing could actually help identify women that may be at LOWER risk for breast cancer, and could potentially defer their mammogram screenings by 5-10 years. bit.ly/3voC81u
3
6
712
Check out what we achieved in 2023!
#OnTheBlog: Our 2023 highlights include expanding collaborations with leading health systems to transform care, building a clinico-genomic dataset to accelerate drug development and emphasizing health equity to make healthcare more accessible for all. bit.ly/3GTfdha
2
105
Great work from the team at @my_helix for getting this news out before the holidays and in time to have a clinical impact on the current surge in COVID-19 cases.
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
82
Using tokenization, we were able to leverage our SARS-CoV-2 diagnostic testing data to create a cohort of over 30,000 individuals to answer an important clinical question: how frequent is SARS-CoV-2 rebound in the real world?
1
58
shishi luo retweeted
#OnTheBlog: New RWE analysis conducted with @pfizer analyzes the rate of viral SARS-CoV-2 rebound in those treated with NMV-r compared to untreated patients. Click here to learn whether they occurred at a higher rate or what their severity was like: bit.ly/3GCRt0N
3
2
2
709
HV.1 is dominant, and is growing in frequency. But it may be leading to less severe infections. @my_helix's epi monitoring data suggests HV.1 is associated with a 10% (29/286) rate of hospitalization compared to 16% (393/2,501) for other variants, including EG.5 (p-val 0.01).
1
1
1
1
778
After adjusting for confounders, we estimate a 32% reduced risk of hospitalization in HV.1 patients compared to other variants over the same time period (p-val 0.02). (We adjusted for health system, age group, sex, race/ethnicity, date, and COVID vaccination status.)
1
160
The 2,787 specimens were collected across three health systems in the period Aug 9-Oct 23. Big thanks to @my_helix for creating this real-time monitoring system and Matt Levy for the analysis. @Maglaar @alexbolze
1
103
shishi luo retweeted
#InTheNews: @shishiluo, Head of Infectious Diseases, spoke w/@medpagetoday about the BA.2.86 variant. "There is "reason to continue to monitor it. The key to the public health response is being able to connect sequencing data with clinical patient data." bit.ly/3Pi42DX
1
559
Call for nominations! @NASEM_Health is seeking experts for a new consensus study, "The Use of Race and Ethnicity in #BiomedicalResearch." Learn more & submit by 7/15 here: ow.ly/3T6x50OUgNv #bioethics
1
41
shishi luo retweeted
#InTheNews This winter, the U.S. saw less COVID cases. Helix's @shishiluo told @ceceliasmith12 at @usnews a level of immunity played a role. Plus, recent variants are Omicron descendants, so the population hasn’t been exposed to a new strain of COVID-19. tinyurl.com/bdd5e4hu
1
540
shishi luo retweeted
NEW: We are working with the @CDCgov to better understand the role of human #genetics in #vaccine effectiveness – particularly across #COVID19 variants – leveraging both our population genomics and viral surveillance expertise. Learn more here: https://nitter.cf/t.co/c292PS3mIV
2
7
746
Great announcement for the end of the year!
Proud to announce we are partnering with @WellSpan on a #populationgenomics initiative aimed at empowering physicians to deliver #precisionhealth care for Pennsylvanians through one of the largest #populationhealth programs in the state. Learn more here: https://nitter.cf/t.co/zQYtb8rIWQ
More signals of moderate surge in SF: @UCSFHospitals asymptomatic test pos. rate now 3.7% (was ~2 last month); 32 Covid patients in my hospital (was 15), & wastewater rising. Overall, Covid risk from same encounter probably twice what it was on 11/1. Get boosted, rethink masks.
47
142
11
595
shishi luo retweeted
#OnTheBlog: For the first time since July, we're seeing slight increases in #COVID positivity, with highest growth in those 18-24 years old. Read about this, as well as, information about reinfections and coinfections with other viruses in our latest post https://nitter.cf/t.co/gINb2NGTqA
1
1